In this e-learning program, three experts explain why it is important to measure Lp(a) levels. Furthermore, they describe the effects of currently available lipid-lowering treatments on Lp(a) levels and talk about potential therapies for Lp(a) lowering which are currently under investigation.

Prof. Stroes describes the effects of currently available lipid-lowering treatments on Lp(a) levels. Futhermore, he talks about potential RNA-based therapies for Lp(a)-lowering, which are currently under investigation.

Prof. Kronenberg talks about the epidemiology and genetic basis of Lp(a) levels and explains why and when Lp(a) should be measured.

Slides as educational service to PACE members and meeting participants.

Slides as educational service to PACE members and meeting participants.

Slides as educational service to PACE members and meeting participants.

What is Lp(a), how common are high Lp(a) levels and what is the relationship with CV events? Prof. Sattar answers these questions in a brief overview. With poll